The European Union (EU) Delegation to Nigeria and ECOWAS, in partnership with the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) and the National Institute for Pharmaceutical Research and Development (NIPRD), will host a high-level Health Investment Forum on October 30, 2025.

The Nigeria–EU Health Investment Forum, themed “Made in Nigeria. Made for Health,” will bring together government officials, industry leaders, development partners, and investors to drive industrialisation and sustainable investment in Nigeria’s healthcare sector.

The event, scheduled for the Bola Ahmed Tinubu International Conference Centre in Abuja, aims to boost local manufacturing, strengthen regulatory systems, and mobilise financing across Nigeria’s pharmaceutical and healthcare value chains.

EU Ambassador to Nigeria and ECOWAS, Gautier Mignot, described the forum as a defining moment for strategic health partnerships.

“This forum brings together government, industry, research, and investors to turn ambition into action for health sovereignty and local production. Through the Global Gateway, the EU and Team Europe are investing in people, systems, and innovation to transform how health products are made, distributed, and accessed across Nigeria and the ECOWAS region,” he said.

Mignot added that the EU is committed to shaping a healthier and more self-reliant future for the region.

“We look forward to signing new partnerships, driving sustainable investments, and co-creating solutions that will reinforce Nigeria’s health security for decades to come,” he noted.

“By aligning our investments with Nigeria’s healthcare reform agenda, we are supporting local producers and innovators to build a stronger and more resilient ecosystem.”

Director-General of NIPRD, Dr. Obi Adigwe, said the forum provides an opportunity to showcase Nigeria’s readiness to lead Africa’s health manufacturing renaissance.

“It will connect policy, innovation, and investment while highlighting NIPRD’s role in driving evidence-based research that supports local pharmaceutical production. Our goal is to make ‘Made in Nigeria, Made for Health’ a reality that delivers sustainable impact across the country and the continent,” Adigwe said.

He added that the collaboration with the EU and PVAC would transform Nigeria’s research outputs into viable industrial solutions.

“Together, we are building the foundations for equitable access to safe, affordable, and high-quality medicines made in Nigeria for Nigerians and beyond,” he said.

Also speaking, the National Coordinator of the Presidential Initiative for Unlocking the Healthcare Value Chain, Dr. Abdu Mukhtar, described the partnership as a turning point for Nigeria’s health sector.

“Through this collaboration with the EU and NIPRD, we are creating the conditions for large-scale private investment, expanding domestic manufacturing, and unlocking the economic potential of the health sector. The initiative is committed to making the healthcare value chain a driver of growth, innovation, and jobs,” he said.

During the forum, participants will sign contracts under the Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+), as well as a regional agreement to be implemented by the West Africa Health Organisation (WAHO) under the Team Europe Sexual and Reproductive Health and Rights (SRHR) Flagship.

These agreements aim to harmonise SRHR policies, expand access to essential health products, and strengthen accountability systems across West Africa.

In addition, PVAC, Bayer AG, and Chromedix Pharmaceuticals Ltd. are expected to announce a strategic partnership to position Nigeria as a continental hub for pharmaceutical innovation, manufacturing, and health sovereignty.

The forum will feature a policy showcase, deal-making sessions, and innovation-led discussions on sustainability, resilience, and equity in healthcare delivery.